Bio Rad Laboratories Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bio Rad Laboratories Inc inventory turnover ratio, the Bio Rad Laboratories Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.62 in the second quarter 2026, yet the ratio remained below the average, as BIO's market remain challenging.Average inventory processing period, for the Bio Rad Laboratories Inc in Jun 30 2026 quarter, has decreased to 225 days, compare to 227 days, in the Mar 31 2026 quarter.

Within Healthcare sector 246 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1691, from total ranking in the first quarter 2026 at 1896.

BIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bio Rad Laboratories Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BIO Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-2.28 %	-2.48 %	-2.54 %	-2.62 %	-0.61 %
Y / Y Cost of Sales Growth	-0.26 %	1.08 %	6.73 %	5.46 %	8.13 %
Inventory Turnover Ratio (TTM)	1.62	1.61	1.6	1.56	1.53
BIO's Total Ranking	# 1691	# 1896	# 1758	# 1767	# 1780
Average inventory processing period	225	227	229	234	239
Seq. Inventory Growth	1.31 %	4.02 %	-5.43 %	-1.95 %	1.1 %
Seq. Cost of Sales Growth	8.23 %	-19.2 %	12.94 %	0.98 %	9.68 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 16
Healthcare Sector	# 247
Overall Market	# 1691

Inventory Turnover Ratio Statistics
High	Average	Low
2.17	1.77	1.45
(Dec 31 2021)		(Jun 30 2012)

BIO Company Profile >> Back to BIO Efficiency Comparisons >> Compare BIO Inventory Turnover Ratio to its Competitors

Financial Statements
Bio Rad Laboratories Inc 's Inventories	$ 781 Millions	Visit BIO's Balance sheet
Bio Rad Laboratories Inc 's Cost of Revenues TTM	$ 1,245 Millions	Visit BIO's Income Statement
What are BIO's Sales?		Visit BIO's Sales by Segment

Other Inventory Turnover Ratios
Bio Rad Laboratories Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BIO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BIO's Competitors
Inventory Turnover Ratio for BIO's Suppliers
Inventory Turnover Ratio for BIO's Customers

You may also want to know
BIO's Sales Growth Rates	BIO's Pe Price to earnings ratio	BIO's Receivables Turnover Ratio	BIO's Stock Quote
BIO's Net Income Growth Rates	BIO's Ps Price to Sales ratio	BIO's Sales per Employee	BIO's Asset Turnover Ratio
BIO's Net Margin	BIO's Pb Price to Book ratio	BIO's Financial Strength Ratios	BIO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Envista Holdings Corporation	4.37	$ 1,278.500 Millions	$ 293 Millions
Myomo Inc	4.23	$ 14.262 Millions	$ 3 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Coherus Oncology inc	4.03	$ 15.822 Millions	$ 4 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Koru Medical Systems Inc	3.97	$ 16.948 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Biocryst Pharmaceuticals Inc	3.69	$ 20.926 Millions	$ 6 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.46	$ 456.703 Millions	$ 132 Millions
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions
Zai Lab Limited	3.39	$ 195.542 Millions	$ 58 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
Evolus Inc	3.37	$ 105.904 Millions	$ 31 Millions
Gilead Sciences Inc	3.35	$ 6,217.000 Millions	$ 1,857 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions

Date modified: 2026-08-14T16:39:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.